Cargando…
Severe Ulcerative Esophagitis Induced by Crizotinib Therapy
Crizotinib is an oral tyrosine-kinase inhibitor that inhibits anaplastic lymphoma kinase (ALK) in gene-rearranged non-small cell lung cancer (NSCLC). In 2011, the Food and Drug Administration approved crizotinib for treatment of locally advanced or metastatic ALK-positive NSCLC. The crizotinib adver...
Autores principales: | Jalil, Ala' A Abdel, Craig, Jamie, Bajaj, Rajesh, Spurling, Timothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Gastroenterology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435292/ https://www.ncbi.nlm.nih.gov/pubmed/26157832 http://dx.doi.org/10.14309/crj.2014.8 |
Ejemplares similares
-
Severe Erosive Pill Esophagitis Induced by Crizotinib Therapy: A Case Report and Literature Review
por: Jung, Patrick, et al.
Publicado: (2016) -
Removal of Esophageal Variceal Bands to Salvage Complete Esophageal Obstruction
por: Jalil, Ala’ A Abdel, et al.
Publicado: (2018) -
Crizotinib-induced Rectal Perforation with Abscess
por: Yanagisawa, Asako, et al.
Publicado: (2017) -
Successful Desensitization with Crizotinib after Crizotinib-induced Liver Injury in ROS1-rearranged Lung Adenocarcinoma
por: Ota, Takayo, et al.
Publicado: (2019) -
Successful Retreatment with Crizotinib After Crizotinib-Induced Liver Failure in ALK-Positive Advanced Lung Adenocarcinoma: A Case Report
por: Zhang, Xiangming, et al.
Publicado: (2023)